# US 2021/0171965 A1 · Nucleic acid constructs and methods of using same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0171965 A1
- Document ID: US20210171965A1
- Status: Published application
- Kind: A1
- Application number: 16/972,779
- Filed: 2019-06-06
- Published: 2021-06-10
- Earliest claimed: 2018-06-07
- Assignees: State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization
- Applicants: The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization
- Inventors: Moshe Arie FLAISHMAN; Reut COHEN PEER; Oded COHEN; Samuel BOCOBZA
- Web page: https://patentgrep.com/patent/US20210171965A1

## CPC

- C12N 15/8213: {Targeted insertion of genes into the plant genome by homologous recombination}
- C12N 15/8216: {Methods for controlling, regulating or enhancing expression of transgenes in plant cells}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A polynucleotide comprising a nucleic acid sequence encoding an expression product of interest under a transcriptional control of a heterologous cis-acting regulatory element comprising a nucleic acid sequence at least 85% identical to SEQ ID NO: 2 (CsUbiquitin10), 4 (CsPs2), 6 (CsActin), 8 (CsTubulin), 10 (Cs EIF), 28 (metallothionein 2A), 30 (Catalase), 32 (Asparagine synthetase), 34 (60S ribosomal protein L3), 38 (40S ribosomal protein S3a), 40 (Phi-1 protein) or 44 (Receptor for activated protein kinase C) is provided. Also provided are nucleic acid constructs and cells comprising same.

## Claims

### Claim 1

A polynucleotide comprising a nucleic acid sequence encoding an expression product of interest under a transcriptional control of a heterologous cis-acting regulatory element comprising a nucleic acid sequence at least 85% identical to SEQ ID NO: 2 (CsUbiquitin10), 4 (CsPs2), 6 (CsActin), 8 (CsTubulin), 10 (Cs EIF), 28 (metallothionein 2A), 30 (Catalase), 32 (Asparagine synthetase), 34 (60S ribosomal protein L3), 38 (40S ribosomal protein S3a), 40 (Phi-1 protein) or 44 (Receptor for activated protein kinase C).

### Claim 2 (depends on 1)

A nucleic acid construct comprising the polynucleotide of claim 1.

### Claim 3

A cloning nucleic acid construct comprising a cis-acting regulatory element comprising a nucleic acid sequence at least 85% identical to SEQ ID NO: 2 (CsUbiquitin10), 4 (CsPs2), 6 (CsActin), 8 (CsTubulin), 10 (Cs EIF), 28 (metallothionein 2A), 30 (Catalase), 32 (Asparagine synthetase), 34 (60S ribosomal protein L3), 38 (40S ribosomal protein S3a), 40 (Phi-1 protein) or 44 (Receptor for activated protein kinase C) and at least one of a multiple cloning site and a selection marker coding sequence.

### Claim 4 (depends on 2)

A cell comprising the nucleic acid construct of claim 2.

### Claim 5 (depends on 4)

The cell of claim 4 being a bacterial cell.

### Claim 6 (depends on 4)

The cell of claim 4 being a plant cell.

### Claim 7 (depends on 2)

A plant or portion thereof comprising the nucleic acid construct of claim 2.

### Claim 8 (depends on 2)

A method of producing a plant, the method comprises, transforming cells of a plant of interest with the nucleic acid construct of claim 2.

### Claim 9 (depends on 8)

The method of claim 8 further comprising regenerating a plant from the plant cells.

### Claim 10 (depends on 9)

The method of claim 9 further comprises selfing or crossing the plant.

### Claim 11 (depends on 2)

The nucleic acid construct of claim 2, wherein the heterologous cis-acting regulatory element comprises a nucleic acid sequence selected from the group consisting of SEQ ID NO: 2 (CsUbiquitin10), 4 (CsPs2), 6 (CsActin), 8 (CsTubulin), 10 (Cs EIF), 28 (metallothionein 2A), 30 (Catalase), 32 (Asparagine synthetase), 34 (60S ribosomal protein L3), 38 (40S ribosomal protein S3a), 40 (Phi-1 protein) and 44 (Receptor for activated protein kinase C).

### Claim 12 (depends on 2)

The nucleic acid construct of claim 2, wherein the heterologous cis-acting regulatory element comprises a nucleic acid sequence selected from the group consisting of SEQ ID NO: 2 (CsUbiquitin10), 4 (CsPs2), 6 (CsActin), 8 (CsTubulin) and 10 (Cs EIF).

### Claim 13 (depends on 2)

The nucleic acid of claim 2, wherein the expression product of interest comprises a DNA editing agent.

### Claim 14 (depends on 6)

The cell of claim 6, wherein the plant is Cannabis saliva.

### Claim 15 (depends on 2)

The nucleic acid construct of claim 2, wherein the expression product of interest comprises an enhanced somatic embryogenesis coding sequence.

### Claim 16 (depends on 2)

The nucleic acid construct of claim 2, wherein the coding sequence is at least 80% identical to SEQ ID NO 45 (CsSERK1) or SEQ ID NO: 47 (CsBBM).

### Claim 17 (depends on 2)

The nucleic acid construct of claim 2, wherein the coding sequence comprises SEQ ID NO 45 (CsSERK1) or SEQ ID NO: 47 (CsBBM).

### Claim 18 (depends on 13)

The nucleic acid construct of claim 13, wherein the DNA editing agent comprises a double strand endonuclease.
